Ultrastable Insulin (AmideBio)

N/A

Report date: 2024/02/28 16:03:38

Base Information

Drug NameUltrastable Insulin (AmideBio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOrnithine decarboxylase stimulantsPhosphokinases stimulantsTYRO3 protein tyrosine kinase stimulants
TargetsOrnithine decarboxylasePhosphokinasesTYRO3 protein tyrosine kinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmideBio LLC
China Registration ClassN/A

Develop Information

Active CompaniesAmideBio LLC
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A